Recently Rated:
Stats
Location:
Work interests:
Affiliation/website:
Preferred contact method:
Preferred contact language(s):
Contact:
Favourite publications:
Work interests:
Affiliation/website:
Preferred contact method:
Preferred contact language(s):
Contact:
Favourite publications:
@ashutosh
• 4 years ago
• comments: 2
RESEARCH EXPERTISES
Expertise in drug development as well as in basic chemistry. This in details involves, all the organic syntheses, purification by recrystallization techniques, all the chromatography methods, NMR, IR, Mass spectroscopy, etc and its pharmacological evaluation against specific targets.
In pharmaceutical chemistry experienced in Molecular hybridization (MH) technique, used to combine two medicinally important scaffolds such as chromene (different benzopyrans /coumarins /flavones) and dihydropyrimidinone).
Utilized heterogeneous catalyst (SiW (H4W12SiO40), PMo (H3PMo12O40), SiMo (H4SiO4Mo12O36), PW (H3PW12O40)) in organic reactions.
In carbohydrate chemistry synthesis of natural molecule mimicking flavones-C-glycosides and coumarin-C-glycoside modulating traditional carbon-Ferrier rearrangement reaction altering it to one pot Mukaiyama type carbon Ferrier rearrangement reaction.
In natural product chemistry I have isolated different natural molecules such as Flavonoids, xanthones, triterpenes and seccoiridoids from the extracts of 5 different plants including Swertia angustifolia, Pinus gerardina, etc. Different techniques were used for the isolation such as Morphological/Anatomical Analysis, TLC/HPTLC analysis, HPLC Analysis, GC Analysis, Spectroscopic Methods: NMR/MS/NIR/FT-IR. Molecular Biological Methods. Natural product isolation (various Xanthones, Oleanolic acid, beta sitosterol, etc.) and semi-synthetic work on Swertia angustifolia.
Applying green chemistry I have developed a novel method for the synthesis of various chromene dihydropyrimidinone (CDHPM) molecules using recyclable Fe/Al pillared clay catalyst and studied their pharmacokinetic parameters like aqueous solubility, lipophilicity, P-glycoprotein (P-gp) dependent ATPase activity, permeability, plasma protein binding, red blood cell (RBC) partitioning, metabolic stability in liver microsomes and in-vitro-in-vivo computations. Also studied ligand interaction for those compounds with LYS 218 &GLN 220 of NF-kB (PDB: 1NF I) as target protein to study the interaction of DHPMs with the target protein.
Expertise in drug development as well as in basic chemistry. This in details involves, all the organic syntheses, purification by recrystallization techniques, all the chromatography methods, NMR, IR, Mass spectroscopy, etc and its pharmacological evaluation against specific targets.
In pharmaceutical chemistry experienced in Molecular hybridization (MH) technique, used to combine two medicinally important scaffolds such as chromene (different benzopyrans /coumarins /flavones) and dihydropyrimidinone).
Utilized heterogeneous catalyst (SiW (H4W12SiO40), PMo (H3PMo12O40), SiMo (H4SiO4Mo12O36), PW (H3PW12O40)) in organic reactions.
In carbohydrate chemistry synthesis of natural molecule mimicking flavones-C-glycosides and coumarin-C-glycoside modulating traditional carbon-Ferrier rearrangement reaction altering it to one pot Mukaiyama type carbon Ferrier rearrangement reaction.
In natural product chemistry I have isolated different natural molecules such as Flavonoids, xanthones, triterpenes and seccoiridoids from the extracts of 5 different plants including Swertia angustifolia, Pinus gerardina, etc. Different techniques were used for the isolation such as Morphological/Anatomical Analysis, TLC/HPTLC analysis, HPLC Analysis, GC Analysis, Spectroscopic Methods: NMR/MS/NIR/FT-IR. Molecular Biological Methods. Natural product isolation (various Xanthones, Oleanolic acid, beta sitosterol, etc.) and semi-synthetic work on Swertia angustifolia.
Applying green chemistry I have developed a novel method for the synthesis of various chromene dihydropyrimidinone (CDHPM) molecules using recyclable Fe/Al pillared clay catalyst and studied their pharmacokinetic parameters like aqueous solubility, lipophilicity, P-glycoprotein (P-gp) dependent ATPase activity, permeability, plasma protein binding, red blood cell (RBC) partitioning, metabolic stability in liver microsomes and in-vitro-in-vivo computations. Also studied ligand interaction for those compounds with LYS 218 &GLN 220 of NF-kB (PDB: 1NF I) as target protein to study the interaction of DHPMs with the target protein.